Advanced in Brain Tumor

Frank A. Giordano

Mannheim, BW, DE 
Advanced in Brain Tumor
Mannheim, BW, DE 
OverviewLocationsClinical Research

Overview

Frank Giordano practices in Mannheim, Germany. Mr. Giordano is rated as an Advanced expert by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Vertebroplasty, and Vasectomy.

His clinical research consists of co-authoring 181 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 41 articles and participated in 1 clinical trial in the study of Brain Tumor.

Gender
Male

Locations

Mannheim, BW, Germany
Other Locations
Heidelberg, BW, Germany
Bonn, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Radiation, Procedure, Drug
Study Drug: Temozolomide
Study Phase: Phase 3
Radiosurgery for the Treatment of Refractory Ventricular Extrasystoles and Tachycardias (RAVENTA)
Radiosurgery for the Treatment of Refractory Ventricular Extrasystoles and Tachycardias (RAVENTA)
Enrollment Status: Completed
Publish Date: January 08, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Intraoperative Radiotherapy During Kyphoplasty/Vertebroplasty (Kypho-IORT) Versus EBRT in the Treatment of Painful Vertebral Metastases - a Randomized Prospective Phase III Study -
Intraoperative Radiotherapy During Kyphoplasty/Vertebroplasty (Kypho-IORT) Versus EBRT in the Treatment of Painful Vertebral Metastases - a Randomized Prospective Phase III Study -
Enrollment Status: Terminated
Publish Date: July 22, 2022
Intervention Type: Radiation
Study Phase: Phase 3
Intraoperative Radiotherapy After the Resection of Brain Metastases - a Phase II Feasibility Study
Intraoperative Radiotherapy After the Resection of Brain Metastases - a Phase II Feasibility Study
Enrollment Status: Unknown
Publish Date: June 03, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)
Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)
Enrollment Status: Completed
Publish Date: January 23, 2019
Intervention Type: Device
Study Phase: Not Applicable
Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Change in the Curative-intended, Radical Radiotherapy of Locally Advanced NSCLC
Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Change in the Curative-intended, Radical Radiotherapy of Locally Advanced NSCLC
Enrollment Status: Completed
Publish Date: May 02, 2018
View 6 Less Clinical Trials

181 Total Publications

Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study.
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study.
Journal: Clinical and translational radiation oncology
Published: July 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Giordano's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile